| pubmed-article:15226523 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15226523 | lifeskim:mentions | umls-concept:C0002423 | lld:lifeskim |
| pubmed-article:15226523 | lifeskim:mentions | umls-concept:C0149871 | lld:lifeskim |
| pubmed-article:15226523 | lifeskim:mentions | umls-concept:C0019139 | lld:lifeskim |
| pubmed-article:15226523 | lifeskim:mentions | umls-concept:C0020003 | lld:lifeskim |
| pubmed-article:15226523 | lifeskim:mentions | umls-concept:C0085550 | lld:lifeskim |
| pubmed-article:15226523 | lifeskim:mentions | umls-concept:C1280519 | lld:lifeskim |
| pubmed-article:15226523 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15226523 | pubmed:dateCreated | 2004-6-30 | lld:pubmed |
| pubmed-article:15226523 | pubmed:abstractText | This study was conducted at Centenary Health Centre of the Rouge Valley Health System, a community based hospital in Toronto. In January 1997, a new treatment was introduced for the management of patients with uncomplicated deep vein thrombosis (DVT). Eligible patients presenting at the ER were placed on LMWH (tinzaparin) and followed at home. Previously the patients had been hospitalized and treated with intravenous heparin until they reached a therapeutic international normalized ratio (INR). The intent of this study was to evaluate the patient outcomes and cost-savings of the new approach. | lld:pubmed |
| pubmed-article:15226523 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15226523 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15226523 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15226523 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15226523 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15226523 | pubmed:issn | 1198-581X | lld:pubmed |
| pubmed-article:15226523 | pubmed:author | pubmed-author:PaoDavidD | lld:pubmed |
| pubmed-article:15226523 | pubmed:author | pubmed-author:HsuTomT | lld:pubmed |
| pubmed-article:15226523 | pubmed:author | pubmed-author:LeeMingM | lld:pubmed |
| pubmed-article:15226523 | pubmed:author | pubmed-author:SonderskovAnn... | lld:pubmed |
| pubmed-article:15226523 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15226523 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:15226523 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15226523 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15226523 | pubmed:pagination | e17-27 | lld:pubmed |
| pubmed-article:15226523 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15226523 | pubmed:meshHeading | pubmed-meshheading:15226523... | lld:pubmed |
| pubmed-article:15226523 | pubmed:meshHeading | pubmed-meshheading:15226523... | lld:pubmed |
| pubmed-article:15226523 | pubmed:meshHeading | pubmed-meshheading:15226523... | lld:pubmed |
| pubmed-article:15226523 | pubmed:meshHeading | pubmed-meshheading:15226523... | lld:pubmed |
| pubmed-article:15226523 | pubmed:meshHeading | pubmed-meshheading:15226523... | lld:pubmed |
| pubmed-article:15226523 | pubmed:meshHeading | pubmed-meshheading:15226523... | lld:pubmed |
| pubmed-article:15226523 | pubmed:meshHeading | pubmed-meshheading:15226523... | lld:pubmed |
| pubmed-article:15226523 | pubmed:meshHeading | pubmed-meshheading:15226523... | lld:pubmed |
| pubmed-article:15226523 | pubmed:meshHeading | pubmed-meshheading:15226523... | lld:pubmed |
| pubmed-article:15226523 | pubmed:meshHeading | pubmed-meshheading:15226523... | lld:pubmed |
| pubmed-article:15226523 | pubmed:meshHeading | pubmed-meshheading:15226523... | lld:pubmed |
| pubmed-article:15226523 | pubmed:meshHeading | pubmed-meshheading:15226523... | lld:pubmed |
| pubmed-article:15226523 | pubmed:meshHeading | pubmed-meshheading:15226523... | lld:pubmed |
| pubmed-article:15226523 | pubmed:meshHeading | pubmed-meshheading:15226523... | lld:pubmed |
| pubmed-article:15226523 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15226523 | pubmed:articleTitle | Cost savings and effectiveness of outpatient treatment with low molecular weight heparin of deep vein thrombosis in a community hospital. | lld:pubmed |
| pubmed-article:15226523 | pubmed:affiliation | Pharmacy Services, Rouge Valley Health System, Toronto, Canada. | lld:pubmed |
| pubmed-article:15226523 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15226523 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15226523 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
